Quantcast
Home > Quotes > ATRI

Atrion Corporation Common Stock (ATRI) Quote & Summary Data

ATRI 
$625.8
*  
9.40
1.52%
Get ATRI Alerts
*Delayed - data as of Jul. 18, 2018  -  Find a broker to begin trading ATRI now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    ATRI After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
300
Today's High / Low
$ 625.80 / $ 615
Share Volume
1,766
50 Day Avg. Daily Volume
9,365
Previous Close
$ 616.40
52 Week High / Low
$ 694 / $ 516.85
Market Cap
1,158,882,724
P/E Ratio
33.08
Forward P/E (1y)
Earnings Per Share (EPS)
$ 18.92
Annualized Dividend
$ 4.80
Ex Dividend Date
6/14/2018
Dividend Payment Date
6/29/2018
Current Yield
0.79 %
Beta
0.34

Intraday Chart

Shares Traded

Share Volume:
1,766
50 Day Avg. Daily Volume:
9,365

P/E Ratio

P/E Ratio:
33.08
Forward P/E (1y):
Earnings Per Share (EPS):
$ 18.92

Trading Range

The current last sale of $625.80 is 21.08% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 625.80 $ 694
 Low: $ 615 $ 516.85

Company Description (as filed with the SEC)

Atrion Corporation and its subsidiaries ("we," "our," "us," "Atrion," or the "Company") develop and manufacture products, primarily for medical applications. Our medical products are used in a number of fields including fluid delivery, cardiovascular and ophthalmology applications. Our fluid delivery products accounted for 44 percent of net revenues for 2017 and 42 percent of net revenues for both 2016 and 2015. We have developed a wide variety of proprietary valves designed to precisely fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in fields such as anesthesia and oncology. We make products that deliver fluids, as well as promote infection control in hospital and home healthcare environments. Our cardiovascular products accounted for 33 percent of net revenues for both 2017 and 2016 and 32 percent of net revenues for 2015.  ... More ...  

Risk Grade

Where does ATRI fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 616.45
Open Date:
Jul. 18, 2018
Close Price:
$ 625.80
Close Date:
Jul. 18, 2018

Consensus Recommendation

Analyst Info